The risk of viral rebound in the year after delivery in women remaining on antiretroviral therapy

AIDS

Volumn 29, Issue 17, 2015, Pages 2269-2278

  Huntington, S ^b   Thorne, C ^z   Newell, Marie Louise ^c   Anderson, J ^d,z   Taylor, Graham P ^e   Pillay, D ^z   Hill, T ^b   Tookey, Pat A ^a   Sabin, C ^b   Ainsworth, J ^o,z   Allan, S ^u,z   Babiker, A ^z   Chadwick, D ^s,z   Delpech, V ^k,z   Dunn, D ^g   Fisher, M ^i,z   Gazzard, B ^j,z   Gilson, R ^m,z   Gompels, M ^n,z   Hay, P ^v,z   Johnson, M ^b,z   Kegg, S ^t,z   Leen, C ^q,z   Martin, F ^w,z   Nelson, M ^j,z   Orkin, C ^h,z   Palfreeman, A ^r,z   Phillips, A ^b   Post, F ^l,z   Pritchard, J ^y,z   Schwenk, A ^o,z   Tariq, A ^x,z   Trevelion, R ^z   Walsh, J ^p,z   Jose, S ^b   Thornton, A ^b   Glabay, A ^g   Lynch, J ^h   Hand, J ^h   De Souza, C ^h   Perry, N ⁱ   Tilbury, S ⁱ   Churchill, D ⁱ   Waxman, M ^j   Asboe, D ^j   Mandalia, S ^j   Munshi, S ^d   Awosika, D ^d   Korat, H ^l   Taylor, C ^l   Gleisner, Z ^l   Ibrahim, F ^l   Campbell, L ^l   Brima, N ^m   Williams, I ^m   Allen, S ⁿ   Wood, C ^o   Miller, S ^o   Youle, M ^b   Lampe, F ^b   Smith, C ^b   Grabowska, H ^b   Chaloner, C ^b   Puradiredja, D ^b   Mackie, N ^p   Winston, A ^p   Weber, J ^p   Ramzan, F ^p   Wilson, A ^q   Moore, A ^r   Fox, L ^r   Baillie, K ^s   Main, P ^t   Dhillon, M ^v   Douglas, S ^w   Cortina Borja, M ^z   Brown, A ^z   De Ruiter, A ^z   Donaghy, S ^z   Farthing, S ^z   Harding, K ^z   Judd, A ^z   Logan, L ^z   Lyall, H ^z   Namiba, A ^z   Ncube, F ^z   Peckham, C ^z   Primrose, L ^z   Tookey, P ^z   Webb, S ^z   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f UNIVERSITY OF KWAZULU NATAL   (South Africa)

^g MEDICAL RESEARCH COUNCIL   (United Kingdom)

^h BARTS HEALTH NHS TRUST   (United Kingdom)

ⁱ Worthing Hospital   (United Kingdom)

^j CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^k PUBLIC HEALTH ENGLAND   (United Kingdom)

^l KING S COLLEGE HOSPITAL   (United Kingdom)

^m ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

ⁿ NORTH BRISTOL NHS TRUST   (United Kingdom)

^o NORTH MIDDLESEX UNIVERSITY HOSPITAL NHS TRUST   (United Kingdom)

^p IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^q NHS LOTHIAN   (United Kingdom)

^r UNIVERSITY OF LEICESTER   (United Kingdom)

^s SOUTH TEES HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^t Woolwich NHS Trust   (United Kingdom)

^u UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^v St George's NHS Trust   (United Kingdom)

^w YORK TEACHING HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^x ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST   (United Kingdom)

^y ASHFORD AND ST PETER'S HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^z Royal Wolverhampton NHS Trust ^*

more..

Author keywords

adherence; HAART; HIV; postpartum women; pregnant women; viral load

Indexed keywords

ANTIVIRUS AGENT; EFAVIRENZ; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; VIRUS RNA; ANTIRETROVIRUS AGENT;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COMBINATION ANTIRETROVIRAL THERAPY; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MIXED INFECTION; PARITY; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; SENSITIVITY ANALYSIS; TREATMENT DURATION; VIRAL PHENOMENA AND FUNCTIONS; VIRAL REBOUND; VIRUS LOAD; BIRTH; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; IRELAND; KAPLAN MEIER METHOD; MIDDLE AGED; RECURRENT DISEASE; RISK ASSESSMENT; UNITED KINGDOM; VIROLOGY;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; IRELAND; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; PARTURITION; POSTPARTUM PERIOD; PREGNANCY; RECURRENCE; RISK ASSESSMENT; UNITED KINGDOM; VIRAL LOAD;

EID: 84957634161     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000826     Document Type: Article

References (31)

1. Williams I, Churchill D, Anderson J, Boffito M, Bower M, Cairns G, et al. British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012 (Updated November 2013). HIV Med 2014; 15 Suppl 1:1-85.
2. Huntington SE, Thorne C, Bansi LK, Anderson J, Newell ML, Taylor GP, et al. Predictors of pregnancy and changes in pregnancy incidence among HIV-positive women accessing HIV clinical care. AIDS 2013; 27:95-103.
3. NSHPC. Routine NSHPC quarterly slides: slide 7. July 2014. www.nshpc.ucl.ac.uk [Accessed 25 July 2015]
4. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: WHO; 30 June 2013. www.who.int/hiv/pub/guidelines/arv2013/down load/en/ [Accessed 25 July 2015]
5. de Ruiter A, Taylor GP, Clayden P, Dhar J, Ghandi K, Gilleece Y, et al. British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review). HIV Med 2014; 15 Suppl 4:1-77.
6. Cao Y, Krogstad P, Korber BT, Koup RA, Muldoon M, Macken C, et al. Maternal HIV-1 viral load and vertical transmission of infection: The Ariel Project for the prevention of HIV transmission from mother to infant. Nat Med 1997; 3:549-552.
7. Melo VH, Pinto JA, Freimanis-Hance L, Gutierrez C, Peixoto M, Santos B, et al. Postpartum changes in plasma viral load and CD4 percentage among HIV-infected women from Latin American and Caribbean countries: The NISDI Perinatal Study. Mem Inst Oswaldo Cruz 2011; 106:97-104.
8. Ekpini RA, Nkengasong JN, Sibailly T, Maurice C, Adje C, Monga BB, et al. Changes in plasma HIV-1-RNA viral load and CD4 cell counts, and lack of zidovudine resistance among pregnant women receiving short-course zidovudine. AIDS 2002; 16:625-630.
9. Watts DH, Lambert J, Stiehm ER, Harris DR, Bethel J, Mofenson L, et al. Progression of HIV disease among women following delivery. J Acquir Immune Defic Syndr 2003; 33:585-593.
10. Sha BE, Tierney C, Cohn SE, Sun X, Coombs RW, Frenkel LM, et al. Postpartum viral load rebound in HIV-1-infected women treated with highly active antiretroviral therapy: AIDS Clinical Trials Group Protocol A5150. HIV Clin Trials 2011; 12:9-23.
11. Bryson YJ, Mirochnick M, Stek A, Mofenson LM, Connor J, Capparelli E, et al. Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353. HIV Clin Trials 2008; 9:115-125.
12. Townsend CL, Byrne L, Cortina-Borja M, Thorne C, de RA, Lyall H, et al. Earlier initiation of ART and further decline in motherto-child HIV transmission rates, 2000-2011. AIDS 2014; 28:1049-1057.
13. Huntington SE, Bansi LK, Thorne C, Anderson J, Newell ML, Taylor GP, et al. Using two on-going HIV studies to obtain clinical data from before, during and after pregnancy for HIVpositive women. BMC Med Res Methodol 2012; 12:110.
14. Cavallo IK, Kakehasi FM, Andrade BA, Lobato AC, Aguiar RA, Pinto JA, et al. Predictors of postpartum viral load rebound in a cohort of HIV-infected Brazilian women. Int J Gynaecol Obstet 2010; 108:111-114.
15. Bardeguez AD, Lindsey JC, Shannon M, Tuomala RE, Cohn SE, Smith E, et al. Adherence to antiretrovirals among US women during and after pregnancy. J Acquir Immune Defic Syndr 2008; 48:408-417.
16. Mellins CA, Chu C, Malee K, Allison S, Smith R, Harris L, et al. Adherence to antiretroviral treatment among pregnant and postpartumHIV-infectedwomen. AIDSCare 2008; 20:958-968.
17. Turner BJ, Newschaffer CJ, Zhang D, Cosler L, Hauck WW. Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women. Med Care 2000; 38:911-925.
18. Vaz MJ, Barros SM, Palacios R, Senise JF, Lunardi L, Amed AM, et al. HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women. Int J STD AIDS 2007; 18:28-32.
19. Bailey H, Thorne C, Malyuta R, Townsend CL, Semenenko I, Cortina-Borja M. Adherence to antiretroviral therapy during pregnancy and the first year postpartum among HIV-positive women in Ukraine. BMC Public Health 2014; 14:993.
20. Saulsbury N, Forsyth SF, Thornburn D, Baruah J, Whyte P. Patterns of attendance post-delivery for antenatally diagnosed HIV positive women [Abstract P57]. The British HIV Association (BHIVA) Spring Conference; 15-17 April 2004; Cardiff, Wales.
21. Stein MD, Crystal S, Cunningham WE, Ananthanarayanan A, Andersen RM, Turner BJ, et al. Delays in seeking HIV care due to competing caregiver responsibilities. Am J Public Health 2000; 90:1138-1140.
22. Buchberg MK, Fletcher FE, Vidrine DJ, Levison J, Peters MY, Hardwicke R, et al. A mixed-methods approach to understanding barriers to postpartum retention in care among lowincome, HIV-infected women. AIDS Patient Care STDS 2015; 29:126-132.
23. Tenthani L, Haas AD, Tweya H, Jahn A, van Oosterhout JJ, Chimbwandira F, et al. Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women ('Option BR') in Malawi. AIDS 2014; 28:589-598.
24. Lu L, Adler M, Marston B, Domercant J, Jean-Louis R, Puttkammer N, et al. Retention amongst HIV-infected pregnant women initiating lifelong antiretroviral treatment (Option BR) in Haiti [Abstract 875]. 2015 Conference on Retroviruses and Opportunistic Infections (CROI 2015); 23-26 February 2015; Seattle, WA.
25. French CE, Thorne C, Tariq S, Cortina-Borja M, Tookey PA. Immunologic status and virologic outcomes in repeat pregnancies to HIV-positive women not on antiretroviral therapy at conception: A case for lifelong antiretroviral therapy? AIDS 2014; 28:1369-1372.
26. Danel C, Gabillard D, Le Carrou J, Anglaret X, Moh R, Eholie S, et al. Early ART and IPT in HIV-infected African adults with high CD4 count (Temprano Trial) [Abstract 115LB]. 2015 Conference on Retroviruses and Opportunistic Infections (CROI 2015); 23-26 February 2015; Seattle, WA.
27. Williams I, Churchill D, Anderson J, Boffito M, Bower M, Cairns G, et al. British HIV Association (BHIVA) guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012. HIV Med 2012; 13 Suppl 2:1-85.
28. Bartlett JA, DeMasi R, Quinn J, Moxham C, Rousseau F. Overview of the effectiveness of triple combination therapy in antiretroviral-naive HIV-1 infected adults. AIDS 2001; 15: 1369-1377.
29. de Ruiter A, Mercey D, Anderson J, Chakraborty R, Clayden P, Foster G, et al. British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008. HIV Med 2008; 9:452-502.
30. Ford N, Mofenson L, Shubber Z, Calmy A, Andrieux-Meyer I, Vitoria M, et al. Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis. AIDS (28 Suppl 2):2014:S123-S131.
31. Airoldi M, Zaccarelli M, Bisi L, Bini T, Antinori A, Mussini C, et al. One-pill once-A-day HAART: A simplification strategy that improves adherence and quality of life of HIV-infected subjects. Patient Prefer Adherence 2010; 4:115-125.